itraconazole has been researched along with Community Acquired Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashiyama, Y; Hirakata, Y; Kohno, S; Miyazaki, Y; Mizuta, Y; Nakamura, S; Ohno, H; Shikuwa, M; Tashiro, T; Yanagihara, K | 1 |
| Brown, P; Jandourek, A; Vazquez, JA | 1 |
2 other study(ies) available for itraconazole and Community Acquired Infection
| Article | Year |
|---|---|
Community acquired pneumonia (CAP) caused by Cryptococcus neoformans in a healthy individual.
Topics: Adult; Antifungal Agents; Community-Acquired Infections; Cryptococcosis; Humans; Itraconazole; Male; Pneumonia | 2005 |
Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clotrimazole; Community-Acquired Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Fungemia; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged | 1999 |